Closed
Licensed Bulk Medicines
Descriptions
We are interested in buying the following list of products, in licensed bulk containers of up to the sizes noted below, to be available within a 5 year timeframe. We consider the availability in licensed bulk presentation to be a significant market advantage and are willing to consider entering contracts for supply with suppliers who can meet this presentation requirement for these products.Estimated value in the Wales market of this list is £42,317,736.61 p/a at current prices.The list is not exhaustive, and we are willing to consider other generic and biosimilar products if licensed bulk presentation can be offered.Drug,Strength,Proposed Vial SizeARSENIC TRIOXIDE,1mg/mL,AZACITIDINE,25mg/mL,500mLBEVACIZUMAB,25mg/mL,100mL - 250mLBORTEZOMIB,2.5mg/mL,50mLCALCIUM FOLINATE,10mg/mL,1000mLCARBOPLATIN,10mg/mL,1000mLCETUXIMAB,5mg/mL,250m – 500mLCISPLATIN,1mg/mL,500mL - 1000mLCYCLOPHOSPHAMIDE,20mg/mL,500mLCYTARABINE,100mg/mL or 20mg/mL,250mLDARATUMUMAB,20mg/mL,100mL – 250mLDOCETAXEL,20mg/mL,250mL - 500mLDOXORUBICIN,2mg/mL,1000mLEPIRUBICIN,2mg/mL,1000mLETOPOSIDE,20mg/mL,500mLFLUCLOXACILLIN,,3000mLFLUOROURACIL,50mg/mL or 25mg /mL,250-500mLINFLIXIMAB,10mg/mL,500mL - 1000mLIRINOTECAN,20mg/mL,1000mLNIVOLUMAB,10mg/mL,250mLOXALIPLATIN,5mg/mL,500mL-1000mLPACLITAXEL,6mg/mL,1000mLPEMBROLIZUMAB,25mg/mL,100mL – 250mLPEMETREXED,25mg/mL,100mL – 250mLPIPERACILLIN & TAZOBACTAM,,3000mLRITUXIMAB,10mg/mL,500mLTOCILIZUMAB,20mg/mL,250mLTRASTUZUMAB EMTANSINE,20mg/mL,100mL - 250mLVEDOLIZUMAB,60mg/mL,250mLVITLIPID N INFANT,N/A,250mLPlease inform us via the contact information above if you are able to provide these products.
Timeline
Pretender :
Not Identified
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
CPV Codes
33600000 - Pharmaceutical products
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors